Sort
65,743 grants matching “single cell sequencing”
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer
$695,331Jesse Samuel Boehm · Massachusetts Institute Of Technology · R01 · FY2022 · CA
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm
$695,275Mary E Patti · Joslin Diabetes Center · R01 · FY2024 · DK
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
$695,258Jethro Hu · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Cell Identity Determination In Human Brain: Somatic mutation and cell lineage
$695,233Christopher A Walsh · Boston Children'S Hospital · R01 · FY2022 · NS
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.
$695,223David G Russell · Cornell University · R01 · FY2023 · AI
Structural biology of telomerase and telomeres
$695,218Juli F Feigon · University Of California Los Angeles · R35 · FY2025 · GM
Probabilistic Multiscale Modeling of the Tumor Microenvironment
$695,214Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids
$695,214Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2022 · DA
Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids
$695,214Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2021 · DA
Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids
$695,214Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2023 · DA
Resolution of inflammation in healing myocardial infarcts
$695,191Nikolaos G Frangogiannis · Albert Einstein College Of Medicine · R01 · FY2024 · HL
IMPACT OF LOSS OF THE AUTISM RISK GENE CHD8 ON EXPRESSION, EPIGENETICS AND CELLULAR FUNCTIONING OF THE DOPAMINERGIC SYSTEM
$695,147Rebecca Ann Muhle · Columbia University Health Sciences · R01 · FY2024 · MH
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$695,125Antonio M Omuro · Yale University · R01 · FY2022 · CA
3D genome reorganization drives cancer development
$695,123Mandar Deepak Muzumdar · Yale University · R01 · FY2024 · CA
Investigating hypoxia as a determinant of malignant fates in pancreas cancer
$695,122Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
3D genome reorganization drives cancer development
$695,122Mandar Deepak Muzumdar · Yale University · R01 · FY2025 · CA
Cell-derived therapies for corneal nerve repair: Structural and functional mechanisms
$695,037Ali R Djalilian · University Of Illinois At Chicago · R01 · FY2024 · EY
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$695,031William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
$695,029Charles L Sawyers · Columbia University Health Sciences · P01 · FY2022 · CA
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · University Of Utah · R01 · FY2024 · AI
Mechanisms of Auditory Circuit Development
$694,983Ulrich Mueller · Johns Hopkins University · R01 · FY2022 · DC
Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution
$694,964Cristina Maria Alvira · Stanford University · R01 · FY2023 · HL
Multimodal omics approach to identify health to cardiometabolic disease transitions
$694,961Paivi Pajukanta · University Of California Los Angeles · R01 · FY2025 · HL
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$694,960Luc Teyton · Scripps Research Institute, The · U01 · FY2025 · AI